Brooklyn Park, MN, United States of America

Michael G Klug

This inventor holds 4 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2004-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael G Klug. Retrieved from https://idiyas.com/inventor/michael-g-klug

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Denver, CO (US) (2004)
  • Brooklyn Park, MN (US) (2006 - 2007)

Company Filing History:


Years Active: 2004-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Michael G Klug: Innovator in Pharmaceutical Chemistry

Introduction

Michael G Klug is a notable inventor based in Brooklyn Park, MN (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work focuses on developing compounds that have the potential to treat various health conditions.

Latest Patents

Among his latest patents are innovations related to quinoline derivatives. These compounds, described by specific formulas, can be utilized in pharmaceutical preparations aimed at treating or preventing arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, and obesity. The versatility of these compounds highlights their importance in modern medicine.

Career Highlights

Michael G Klug is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His role involves extensive research and development, contributing to the advancement of medical treatments through innovative compounds.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues such as Patrizio Mattei and Matthias Heinrich Nettekoven. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Michael G Klug's contributions to pharmaceutical chemistry are noteworthy, particularly in the development of quinoline derivatives for various health applications. His work continues to influence the field and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…